% | $
Quotes you view appear here for quick access.

MiMedx Group, Inc. Message Board

  • tipsmaster tipsmaster May 23, 2014 10:23 AM Flag

    Shorts on borrowed time

    What our future can easily look like ....
    "Shares of PTC Therapeutics (PTCT) are up over 150% to $39.00 in pre-market trading after the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion regarding the company's application for a conditional marketing authorization of Translarna for the treatment of nonsense mutation Duchenne muscular dystrophy, or nmDMD, in ambulatory patients aged five years and older. Shares of Prosensa (RNA), which is also seeking EU approval for its own DMD treatment, is up more than 20% to $8.00 in pre-market trading."

    SortNewest  |  Oldest  |  Most Replied Expand all replies
7.22+0.21(+3.00%)May 23 4:00 PMEDT